Rodeghiero, Francesco http://orcid.org/0000-0003-2253-2502
Carli, Giuseppe
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 27 December 2016
Accepted: 13 February 2017
First Online: 8 March 2017
Compliance with ethical standards
:
: FR has served on Advisory Boards/Speaker’s Bureaus for Amgen, GSK/Novartis, LFB, MedImmune, UCB and Argenx, all outside the submitted work. GC has no conflicts of interest to disclose.